top of page

BioVenture VoiCes Episode 7: MPM BioImpact's Ansbert Gadicke

  • blonca9
  • Dec 2, 2024
  • 1 min read

MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment collaborators. Plus, the keys making it through a down cycle like the industry has been in over recent years.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page